Characteristics | No. of patients | % |
---|---|---|
Pathological type | ||
Classical PTC | 60 | 89.55% |
Diffuse sclerosing carcinoma | 3 | 4.69% |
Insular carcinoma | 1 | 1.56% |
Combined pathology | ||
Hashimoto’s thyroiditis, HT | 20 | 31.25% |
Nodular Goiter | 11 | 17.19% |
Multifocality | ||
Single | 45 | 70.31% |
Multiple(≥ 2) | 19 | 29.69% |
Tumor location | ||
Unilateral | 48 | 75.00% |
Left lobe | 29 | 45.31% |
Right lobe | 19 | 29.69% |
Bilateral | 16 | 25.00% |
Tumor size | ||
≤ 1 cm | 15 | 23.44% |
> 1, ≤ 2 cm | 20 | 31.25% |
> 2, ≤ 4 cm | 26 | 40.63% |
> 4 cm | 3 | 4.69% |
Extrathyroidal invasion | ||
Yes | 27 | 42.19% |
No | 37 | 57.81% |
T classification | ||
T1 | 26 | 40.63% |
T1a | 10 | 15.63% |
T1b | 16 | 25.00% |
T2 | 11 | 17.19% |
T3 | 17 | 26.56% |
T3a | 1 | 1.56% |
T3b | 16 | 25.00% |
T4 | 10 | 15.63% |
T4a | 10 | 15.63% |
T4b | 0 | 0% |
N classification (imaging and clinical) a | ||
N0 | 11 | 17.19% |
N1a | 53 | 82.81% |
N1b | 41 | 64.06% |
M classification (imaging and clinical)b | ||
M0 | 58 | 84.38% |
M1 | 6 | 11.11% |
RAI after surgery | ||
Yes | 30 | 46.88% |
No | 34 | 53.13% |